Latitude Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,004
| Closed | -$540K | – | 325 |
|
|
2022
Q1 | $540K | Buy |
6,004
+1,651
| +38% | +$148K | 0.12% | 168 |
|
|
2021
Q4 | $487K | Buy |
4,353
+146
| +3% | +$16.3K | 0.14% | 155 |
|
|
2021
Q3 | $529K | Buy |
4,207
+2,389
| +131% | +$300K | 0.17% | 128 |
|
|
2021
Q2 | $246K | Buy |
1,818
+64
| +4% | +$8.66K | 0.18% | 139 |
|
|
2021
Q1 | $238K | Buy |
1,754
+259
| +17% | +$35.1K | 0.2% | 128 |
|
|
2020
Q4 | $210K | Buy |
+1,495
| New | +$210K | 0.19% | 125 |
|